After months of speculation about a possible takeover of Mirati Therapeutics, Bristol-Myers Squibb has reached a deal to buy the company and its KRAS inhibitor Krazati in a deal valued at up to $5.8 ...
Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
B.M.S. Institute of Technology and Management (BMSIT), Bengaluru Brochure Yes, it offers a 2 year MBA course. Is BMSIT Bengaluru accredited by NAAC? Yes, it is accredited with an ‘A’ grade by NAAC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results